Síndrome de quilomicronemia: aspectos genéticos y revisión de la literatura / Chylomicronemia syndrome: genetic aspects and literature review

Chylomicronemia syndrome is a metabolic condition characterized by severe hypertriglyceridemia and fasting chylomicronemia, secondary to an alteration in the ability to metabolize triglycerides. It can respond to different etiologies, the most frequent being multifactorial. Familial chylomicronemia syndrome, on the other hand, represents an infrequent cause of chylomicronemia syndrome, showing an autosomal recessive inheritance pattern. It's caused by pathogenic variants in genes related to chylomicron's metabolism, mainly LPL1 gene. One of the main associated risks is the occurrence of acute pancreatitis, which can also have a recurrent course. The primary therapy goal in patients with this condition is prevention of pancreatitis and related comorbidities. The treatment basis consists in reduce chylomicron formation by restriction of dietary fat, in association with physical activity and pharmacologic therapy. It is important to distinguish the etiology of chylomicronemia syndrome since it has repercussions in terms of response to treatment, complications, and recurrence risk. (AU)

Biomarcadores cardiacos de aterotrombosis y su implicación en la estimación del riesgo de enfermedad cardiovascular / Cardiac biomarkers of atherothrombosis and their implication in estimating the risk of cardiovascular disease

Introducción: Las innovadoras estrategias para la estimación del riesgo cardiovascular que apelan al empleo de biomarcadores cardiacos de aterotrombosis, han evidenciado ser superiores en la estratificación del riesgo cardiovascular por encima de aquellas predicciones basadas exclusivamente en la evaluación de factores de riesgo tradicionales de manera aislada. Se realizó una revisión bibliográfica, análisis y categorización de diferentes artículos en las bases de datos Cumed, Lilacs, SciELO, Medline, los términos clave para la búsqueda fueron: homocisteína, lipoproteína (a) y riesgo cardiovascular, en español, inglés y portugués. Se consideraron artículos originales, de revisión, incluyendo revisiones sistemáticas y metaanálisis posteriores al año 2000. Objetivo: Analizar los biomarcadores cardiacos de aterotrombosis, involucrados en el desarrollo de la enfermedad cardiovascular aterosclerótica y sus complicaciones trombóticas. Desarrollo: La evidencia acumulada sustenta que biomarcadores cardiacos como la hiperhomocisteinemia, la hiperlipoproteinemia (a), el incremento de los niveles plasmáticos del fibrinógeno, el factor VII coagulante, el inhibidor del activador tisular del plasminógeno tipo 1 y la proteína C reactiva, son herramientas de gran utilidad para estratificar el riesgo cardiovascular en individuos de riesgo intermedio, o con riesgo inusual o de riesgo indefinido, esencialmente en el ámbito de la prevención primaria y secundaria de la enfermedad cardiovascular . Conclusiones: La identificación de biomarcadores emergentes de aterotrombosis predictivos adicionales, es trascendental para una prevención y terapéutica más eficaz de la enfermedad cardiovascular aterosclerótica(AU)

Introduction: Innovative cardiovascular risk estimation strategies that use cardiac biomarkers of atherothrombosis have been shown to be superior in cardiovascular risk stratification that those predictions based exclusively on the evaluation of traditional risk factors in isolation. A bibliographic review, analysis and categorization of different articles was performed in the databases Cumed, Lilacs, Scielo, Medline, the key terms for the search were: "homocysteine", "lipoprotein (a)" and "cardiovascular risk", in Spanish, English and Portuguese languages. Original review articles were considered, including systematic reviews and published meta-analyzes after 2000. Objective: To analyze some of the cardiac biomarkers of atherothrombosis that may be involved in the development of atherosclerotic cardiovascular disease and its thrombotic complications. Development: Accumulated evidence supports that cardiac biomarkers such as: hyperhomocysteinemia, hyperlipoproteinemia (a), increased plasma fibrinogen levels, coagulant factor VII, Plasminogen Tissue Activator Inhibitor type 1 and C-reactive protein are tools of Very useful for stratifying cardiovascular risk in those individuals with intermediate risk, or with unusual or undefined risk, essentially in the field of primary and secondary prevention of cardiovascular disease. Conclusions: The identification of additional predictive emergent atherothrombosis biomarkers is crucial for a more effective prevention and therapy of atherosclerotic cardiovascular disease(AU)

Factores de riesgo metabólico y enfermedad cardiovascular asociados a obesidad en una población laboralmente activa / Metabolic Risk Factors and Cardiovascular Disease Associated with Obesity in an Actively Working Population

Introducción: La obesidad se relaciona con múltiples consecuencias adversas para la salud, como hipertensión, diabetes, hiperlipoproteinemia, enfermedad cardiovascular y otras. La prevalencia de estas entidades se ha incrementado en Cuba en las últimas décadas, muy asociadas a la ganancia ponderal. Objetivo: Describir la relación de la obesidad con la enfermedad cardiovascular y los factores de riesgo metabólicos como hipertensión arterial, hiperlipoproteinemia y diabetes mellitus. Métodos: Se realizó un estudio descriptivo, de corte transversal, en 2902 pacientes que acudieron a chequeo médico en el Hospital Militar Central Dr. Carlos J. Finlay. Se recolectaron datos generales, antropométricos y factores de riesgo metabólico de enfermedad cardiovascular. Se realizó glucemia en ayunas, colesterol, triglicéridos, creatinina y prueba de tolerancia a la glucosa oral en casos indicados. Se calculó el filtrado glomerular. Los pacientes fueron clasificados en bajo peso, normo peso, sobrepeso y obeso, se identificó la relación entre el estado nutricional y los factores de riesgo metabólico y la enfermedad cardiovascular. Resultados: Se encontró 44,5 por ciento de sobrepeso, más frecuente entre los hombres (45,5 por ciento) y 29,2 por ciento de obesidad, más frecuente entre las mujeres (31,6 por ciento). El índice de masa corporal aumentó progresivamente con la edad. Los valores de glucemia, colesterol, triglicéridos, HbA1c y filtrado glomerular aumentaron con el estado nutricional, así como la frecuencia de diabetes, hipertensión, hiperlipoproteinemia y enfermedad cardiovascular. Conclusiones: La obesidad fue muy frecuente en este grupo de pacientes, en los cuales se relacionaron directamente los factores de riesgo metabólico hipertensión arterial, hiperlipoproteinemia, diabetes mellitus y enfermedad cardiovascular(AU)

Introduction: Obesity is associated with multiple adverse health consequences, such as hypertension, diabetes, hyperlipoproteinemia, cardiovascular disease, and others. The prevalence of these conditions has increased in Cuba in recent decades, closely associated with ponderal gain. Objective: To describe the relationship of obesity with cardiovascular disease and metabolic risk factors such as hypertension, hyperlipoproteinemia, and diabetes mellitus. Methods: A descriptive, cross-sectional study was carried out with 2902 patients who went for a medical check-up at Dr. Carlos J. Finlay Central Military Hospital. General, anthropometric and metabolic risk factors for cardiovascular disease were gathered. The tests of fasting blood glucose, cholesterol, triglycerides, creatinine and oral glucose tolerance were performed in indicated cases. Glomerular filtrate was calculated. Patients were classified as low weight, normal weight, overweight, and obese. The relationship between nutritional status and metabolic risk factors and cardiovascular disease was identified. Results: 44.5 percent were found in overweight, more frequent among men (45.5 percent). 29.2 percent were found in obesity, more frequent among women (31.6 percent). The body mass index increased progressively with age. Blood glucose, cholesterol, triglycerides, HbA1c, and glomerular filtration levels increased with nutritional status, as well as the frequency of diabetes, hypertension, hyperlipoproteinemia, and cardiovascular disease. Conclusions: Obesity was very frequent in this group of patients, in which the metabolic risk factors were directly associated with high blood pressure, hyperlipoproteinemia, diabetes mellitus, and cardiovascular disease(AU)

A Case of Type IV Hyperlipoproteinemia with Palmar Xanthoma, Tuberous Xanthoma, and Eruptive Xanthoma / 대한피부과학회지

No abstract available.

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and predominance of small-dense LDL particles. However, in the last decade we have learned that the interaction is much more complex. Hypertriglyceridemia and low HDL-C cannot only be the consequence but also the cause of a disturbed glucose metabolism. Furthermore, it is now well established that statins are associated with a small but significant increase in the risk for new onset diabetes. The underlying mechanisms are not completely understood but modulation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA)-reductase may play a central role as genetic data indicate that mutations resulting in lower HMG CoA-reductase activity are also associated with obesity, higher glucose concentrations and diabetes. Very interestingly, this statin induced increased risk for new onset type 2 diabetes is not detectable in subjects with familial hypercholesterolemia. Furthermore, patients with familial hypercholesterolemia seem to have a lower risk for type 2 diabetes, a phenomenon which seems to be dose-dependent (the higher the low density lipoprotein cholesterol, the lower the risk). Whether there is also an interaction between lipoprotein(a) and diabetes is still a matter of debate.

Xantomatosis eruptiva asociada a hiperlipoproteinemia tipo IV de Fredrickson: a propósito de un caso / Eruptive xanthomatosis associated with Fredrickson type IV hyperlipoproteinemia: case report

Los xantomas cutáneos son una expresión de depósito de lípidos en la piel; pueden ser normolipémicos o dislipémicos, producidos por un defecto genético primario o una alteración metabólica. Las manifestaciones cutáneas de las xantomatosis se presentan con diversas características. Presentamos una paciente joven, sin antecedentes patológicos previos, que consultó por la aparición repentina de lesiones xantomatosas cutáneas, en la cual se arribó al diagnóstico de xantomatosis eruptiva asociadaa trastorno lipídico subyacente. El interés de nuestra presentación radica en que esta afección cutánea puede constituir la única manifestación de las alteraciones de las lipoproteínas, clasificadas dentro del grupo de las dislipidemias de Fredrickson y ser el punto de partida para su diagnóstico y tratamiento oportuno ya que generan un compromiso sistémico y riesgo de vida.

Cutaneous xanthomas are an expression of lipid deposition on the skin. They can be normolipidemic or dyslipidemic and are caused by a primary genetic defect or a metabolic disorder. Cutaneous manifestations of xanthomatosis show various features. We report a young woman with no previous medical history who presented sudden onset of cutaneous xanthomatous lesions, and whose diagnosis showed eruptive xanthomatosis associated with an underlying lipid disorder. The interest of our presentation is that this cutaneous affectation may be the only manifestation of lipoproteins disorders, classified within the group of Fredrickson's dyslipidemias and also the starting point for an appropiate diagnosis and treatment because they generate a systemic commitment and life threatening.

Eruptive Xanthoma in a Child with Type 2 Diabetes Mellitus / 대한피부과학회지

Diabetes mellitus (DM) can be complicated by a variety of cutaneous manifestations. Various xanthoma can appear, according to different subtypes of hyperlipopoteinemia, which is caused by only primary causes, like familial hyperlipoproteinemia, but also secondary causes that is DM, thyroid gland disorder, and diet. Dermatologic findings may even precede any clinical or biological evidence of DM. Thus, cognition of specific dermatologic findings, like xanthoma, can help identify DM, especially in children. We report a case of type IV hyperlipoproteinemia and eruptive xanthoma, associated with DM in a 12-year-old female. She was diagnosed of type IV hyperlipoproteinemia, through a lipid profile, electrophoresis and eruptive xanthoma from a skin biopsy. Although she showed overweight in BMI and had a mother with Type 2 DM, she was too little to have DM, and showed normal urine test. We examined thyroid function test and fasting blood sugar to rule out secondary hyperlipoproteinemia. Fasting blood sugar was increased enough to diagnose her with DM.

[Effect of 8-week walking program on serum lipoprotein [a] concentration in non-athlete menopausal women]

Lipoprotein [a] [Lp[a]] is a new cardiovascular risk factor and its concentration increase cardiovascular diseases, while physical activity decrease cardiovascular diseases. This study intend to investigate the effect of eight week walking program on lipoprotein [a] concentration in non-athlete Iranian menopausal women. Twenty two healthy menopause women of 47-55 year of age any specific disorder were enrolled in this study. The subjects randomly divided into experimental and control groups. Anthropometric characteristics including height, weight, body mass index [BMI], body fat percent and Waist-to-Hip ratio [WHR] and serum lipoprotein on fasting were measured pre and post-walking program. The data were compared using independent t-test, U mann witny and pearson correlation coefficient was used for assessement of relation between lipoprotein [a] with anthropometric indexes. According to these results, there was a significant reduction of serum lipoprotein [a] [pre test12.5 +/- 4/1; post test 10.5 +/- 3md], WHR, BMI and body fat percent prior and after the training in experimental group [P<0.05] while non significant changes was observed in control group. Also, there was non significant relationship between lipoprotein [a] with Anthropometric indexes. This study revealed that 8-week walking program had useful effects on menopausal women' serum lipoprotein [a] concentration, WHR, BMI and body fat percent

Xanthoma of the Rib without Hyperlipoproteinemia: A case report / 대한흉부외과학회지

Primary xanthoma of the bone is a rare benign neoplasm, and it is extremely rare to find this in the ribs. It is most commonly reported in soft tissue and it associated with hyperlipoproteinemia. A 54-years-old male who complained of left chest pain had an X-ray taken. It revealed a left 3rd rib tumor. The blood examinations for lipid and protein were normal. A resection was done for tissue examination. The mass was histolopathologically diagnosed as a xanthoma.

A case of type 3 hyperlipoproteinemia associated with generalized tuberoeruptive xanthomas / 대한내과학회지

A 55-year-old female presented with extensive yellowish eruptive plaques over both elbows and the buttocks that she had first noticed 2 years earlier. Yellowish orange discoloration of her palmar creases was noted. Her serum cholesterol and triglyceride were markedly elevated. Lipoprotein electrophoresis showed a broad beta band. On apolipoprotein E genotyping, the arginine at position 158 had been replaced by cysteine in both alleles (E2/E2). Under a diagnosis of type III hyperlipoproteinemia, combined atorvastatin and fenofibrate therapy for 2 months normalized the serum cholesterol and triglyceride levels.

A Case of Diffuse Plane Xanthoma / 대한피부과학회지

Diffuse plane xanthoma (DPX) was first described by Altman and Winkelmann in 1962. Patients with DPX usually exhibit yellow, flat or slightly elevated plaques that gradually develop on the eyelids, neck, upper trunk, and flexures. Histopathologically, histiocytic foamy cells diffusely spread in the upper dermis with an admixture of lymphocytes and histiocytes. This disease may occur with either hyperlipoproteinemic or normolipoproteinemic states. DPX with hyperlipoproteinemia is associated with familial hyperlipidemia or liver cirrhosis. DPX with normolipoproteinemia is often associated with hematological problems such as multiple myeloma, lymphoma, chronic lymphatic leukemia, chronic myeloid leukemia, and chronic myelomonocytic leukemia. We report a case of diffuse plane xanthoma with hyperlipoproteinemia.

effect of co-administration of aquous extract of bunium persicum and endurance training on plasma lipids in hypercholesterolemic male mice

The effect of endurance training on lipid profile and cardiovascular endurance in normal rat after Bunium Persicum Extract [BPE] administration has been previously investigated. In the present study, the effect of co-administration of endurance training and persicum extract on plasma lipid and lipoproteins in hypercholesterolemic male mice was examined. In this experimental study, 60 male mice were, randomly, divided into 4 groups: Vehicle, Endurance Training [ET], Bunium Persicum Extract Administer [BPEA] and ET-BPEA group. The Exercise protocol was performed at a speed of 18 m/min, 40 min/day, 5 day/week for 6-weeks. The Bunium Persicum Extract was also administered in the same period and the desired dose [0.8 mg] was reconstituted in 0.4 ml of distilled water. The amount of Triglyceride [TG], Total Cholesterol [TC], HDL-c, LDL-c and Body Weight were registered at the beginning and also at the end of the 6 weeks. Data were analysed using one-way ANOVA method. The results indicated that the 6-week endurance training accompanied by Bunium Persicum aquous extract administration reduced TC [pretest; 297.7 +/- 37.08, post test; 146.1 +/- 30.8, p=0.019] and LDL-c concentrations [pretest; 151.8 +/- 14.4, post test; 0.12 +/- 8.7, p=0.00l]. On the other hand, Bunium Persicum aquous extract administration increased HDL-c concentration significantly [pretest; 75.9 +/- 12.1, post test; 119.9 +/- 17.9, p=0.003]. Furthermore, the results showed that body weight changes were not significant. These results suggest that co-administration of BPE and ET could significantly affect plasma lipid and lipoproteins. Therfore performing such program maybe useful for preventing cardiovascular diseases

Lipemia retinalis in a 35-day-old infant with hyperlipoproteinemia: case report / Lipemia retinalis em recém-nascido com 35 dias: relato de caso

A rare case of hyperlipropoteinemia in a 35-day-old infant who presented not only high blood levels of cholesterol and triglycerides but also an ocular manifestation described as lipemia retinalis. The fundoscopic abnormality cleared as the levels of chilomicrons in plasma dropped. Lipemia retinalis is an important and reliable parameter of high levels of chilomicrons and triglycerides and should be considered as a significant clue while diagnosing.

Caso raro de hiperlipoproteinemia em recém-nascido com 35 dias de idade. Identificados altos níveis de colesterol e triglicérides associados a manifestãção ocular descrita como lipemia retinalis. As alterações oculares mostraram melhora uma vez que os níveis séricos foram controlados. Lipemia retinalis é parâmetro confiável e importante a ser considerado como suspeita de alterações de colesterol e triglicérides em crianças e em adultos.

Xantomas eruptivos / Eruptive xantomas

Los xantomas eruptivos son expresión de manifestaciones cutáneas de enfermedades sistémicas, específicamente de hiperlipoproteinemias, entre ellas la hipertrigliceridemia. La enfermedad es poco frecuente, aparece en brotes, se manifiesta por pápulas amarillentas localizadas en nalgas, abdomen, dorso y extremidades y es generalmente asintomática. Afecta a adultos y se asocia a un defecto genético de la lipoprotein-lipasa (LPL) y a un trastorno del metabolismo lipídico. Se presentan 2 casos clínicos de xantomas eruptivos y se realiza una revisión bibliográfica de esta patología y sus posibilidades terapéuticas.

Lipoprotein Analysis in the Elderly Men with Tinnitus / 대한이비인후과학회지

BACKGROUND AND OBJECTIVES: Tinnitus is the conscious experience of sound that originates in the head or neck, and without voluntary origin obvious to that person. The aim of this study was to evaluate the prevalence of dyslipoproteinemias and its correlation with subjective tinnitus in the healthy elderly men (especially in men older than 60 years). SUBJECTS AND METHOD: From January 2007 to January 2008, we randomly selected 150 men at our office visit. Of these men, only 102 complained of subjective tinnitus. All men underwent pure tone audiogram, pitch-match and loudness-balance test for tinnitus, simple X-ray (mastoid series), blood sampling such as total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride and lipoprotein(a) etc, and if necessary, temporal bone imaging study, and vestibular function test. Statistical analyses were performed using the SPSS version 15.0, and the p-value was considered significant when less than 5%. RESULTS: The prevalence of hyperlipoproteinemia had no significant difference between the tinnitus group and the control group. Although there was no correlation between loudness (r=0.008, p>0.05) and pitch (r=0.026, p>0.05) for tinnitus with the serum lipoprotein(a) level, the mean value of serum lipoprotein(a) was significantly different between the two groups (p<0.05). CONCLUSION: The high level of serum lipoprotein(a) may have influence on the subjective tinnitus as a risk or aggravation factor in the healthy elderly men.

A Case of Eruptive Xanthoma Associated withType IV Hyperlipoproteinemia and Koebner Phenomenon / 대한피부과학회지

Type IV hyperlipoproteinemia is characterized by increased blood levels of the triglyceride form of the fat that makes up very low-density lipoproteins (VLDL). Eruptive xanthomas have been frequently observed in type I and V hyperlipoproteinemias but rarely observed in patients with type IV hyperlipoproteinemia. The Koebner phenomenon is the development of the isomorphic skin lesions in persons with certain skin diseases after an injury has occurred on skin of normal appearance. Although this response can develop in psoriasis, lichen planus, verruca etc., it has seldom been associated with eruptive xanthoma. We report a case of eruptive xanthoma with type IV hyperlipoproteinemia and Koebner phenomenon in a 28-year-old Korean male.

Familial combined hyperlipidemia with tuberous and tendinous xanthomas: A case report

Familial combined hyperlipidemia, otherwise known as type IIb hyperlipoproteinemia or multiple lipoprotein-type hyperlipidemia is an inherited disorder of high serum cholesterol or high blood triglycerides. This disease is genetic and inherited, although the specific defective genes have not been identified. The person's cholesterol or triglyceride become elevated during the teenage years and continue to be high throughout life. The types of elevated lipoproteins may vary between affected family members. Its clinical manifestations include lipid disposition on the skin or tendons called "xanthomas" as well as on the arteries. People with this condition have an increased risk of cardiovascular disease so that it is essential to recognize early this type of disorder. We report a case of a 37 year-old male who presented with a bilateral yellowish to reddish nodules on the elbows, knees, ankles, malleoili, ventral aspect of both hands, fingers, feet and toes, metacarpophalangeal & proximal interphalangeal joints, back and buttocks of six years duration with an elevated levels.

A Case of Type IV Hyperlipoproteinemia and Eruptive Xanthoma Associated with Diabetes Mellitus / 대한피부과학회지

We report a case of type IV hyperlipoproteinemia and eruptive xanthoma associated with diabetes mellitus in a 38-year-old male patient. He had multiple, erythematous, yellowish papules on the trunk, extremities and buttocks. Laboratory examinations showed an increase in serum blood glucose, cholesterol and triglyceride. Lipoprotein electrophoresis revealed increased pre-beta bands and a plasma standing test showed turbid plasma. Analysis of lipoprotein revealed an increase of triglyceride levels in the plasma. A skin biopsy from the lesion revealed a xanthoma. We diagnosed the patient as having type IV hyperlipoproteinemia with eruptive xanthoma. After 3 months of treatment with diet restrictions and fenofibrate, the serum level of triglyceride was reduced to a normal level, and the skin lesions disappeared.

Effects of L-carnitine supplementation on serum lipids and apoproteins in hemodialysis patients with LP[a] hyperlipoproteinemia

Lipid abnormalities, especially high serum Lp[a] concentrations, are one of the major causes of cardiovascular diseases in hemodialysis patients. The present study was designed to investigate the effects of L-carnitine supplementation on serum lipids and apoproteins in hemodialysis patients with Lp[a] hyperlipoproteinemia. The study was a randomized clinical trial in which 36 hyper Lp[a] hemodialysis patients [23 males and 13 females] with serum Lp[a] more than 30 mg/dl were randomly assigned to receive either a daily oral carnitine supplement of 1000mg [carnitine group] or no supplement [control group] for 12 weeks. At the baseline and the end of the period 5ml blood were collected after a 12 to 14-hour fast from each patient before dialysis and serum free carnitine, triglyceride, total cholesterol, HDL-C, LDL-C, apoAI, apoB100, Lp[a], IL-6 and albumin were measured. As compared to the initial values, the mean serum free carnitine concentration increased significantly in the carnitine group at the end of the period [P<0.001], while serum triglyceride [P<0.05], total cholesterol [P<0.001] and IL-6 [P<0.001] decreased significantly. No significant changes were observed in the serum concentrations of free carnitine, triglyceride, total cholesterol and IL-6 in the control group. In addition, there were no significant differences between the 2groups as regards mean changes of the serum HDL-C, LDL-C, apoAI, apoB100, Lp[a], and albumin levels. The results of the present study indicate that an L-carnitine supplement has no effect on serum Lp[a] concentration in hemodialysis patients with Lp[a] hyperlipoproteinemia, but it may be effective in preventing cardiovascular diseases by reducing serum triglyceride and total cholesterol concentrations in these patients

Study of lipoprotein patterns as an atherogenic factor in T2DM patients and their FDRS

The present study was carried out to determine the lipoprotein patterns as an atherogenic factor in T2DM [Type 2 Diabetes Mellitus] patients and their FDRS [First Degree Relatives]. In various previous studies it has been reported that hyperinsulinemia and hyperlipidemia frequently coexist in T2DM patients which indicate that the diabetic state it self is associated with atherogenic lipid disorders. The present study included 26 Type 2DM [T2DM] patients and 21 apparently healthy First Degree Relative [FDRs] of T2DM patients. Twenty three age matched control not related to diabetics were also included in the study. The BMI in male patients and FDRs were significantly higher as compared to controls but no significant difference was seen among the BMI of female FDRs. Fasting plasma glucose [FPG] levels of T2DM patients were significantly higher but no significant difference was observed among the FDRs and controls. FPG did not show any significant correlation with the BMI in diabetic patients, FDRs and controls. The lipid profile of patients showed no significant difference, except the mean LDL-Chol of female patients was significantly higher as compared to female controls. HDL-Chol of males FDRs was significantly lower as compared to male controls. LDL-Chol of female FDRs was significantly lower than the female controls. No significant difference was observed in the total cholesterol and the triglycerides level of the patients of T2DM and FDRs but those cases in which pre-beta band appear upon lipoprotein electrophoresis had significantly higher triglyceride levels as compared to those patients in which pre-beta band did not appear. Lipoproteins of the T2DM patients and FDRs group were found to be highly disturbed as compared to the control group and they show a trend of developing atherogenic states in future